金河生物：10月29日召开董事会会议

Group 1 - The core point of the article is that Jinhe Biological announced the convening of its 33rd board meeting on October 29, 2025, to review the third-quarter report for 2025 [1] - For the first half of 2025, Jinhe Biological's revenue composition is as follows: veterinary chemical drugs accounted for 61.83%, agricultural product processing accounted for 19.76%, veterinary biological products accounted for 11.12%, environmental protection business accounted for 4.97%, and others accounted for 2.15% [1] - As of the report date, Jinhe Biological has a market capitalization of 5.2 billion yuan [1] Group 2 - The A-share market has surpassed 4000 points, marking a significant resurgence after a decade of stagnation, with technology leading the market's transformation into a new "slow bull" pattern [1]